Pharmacological Research 1992-01-01

Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes.

E Bosisio, C Benelli, O Pirola

Index: Pharmacol. Res. 25(2) , 147-54, (1992)

Full Text: HTML

Abstract

The effect of several flavanolignans (silicristin, silidianin, silybin and isosilybin) present in silymarin, the extract of Silybum marianum fruits, was tested on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. In microsomes lipid peroxidation was generated by ADP/Fe2+ and NADPH. All flavanolignans inhibited peroxidation in a concentration dependent manner. In hepatocytes lipid peroxidation was induced by ADP/Fe3+ complex and cell damage was evaluated as LDH activity released in the medium. The inhibition of the peroxidative process by flavanolignans was also evident in this model, even if with a potency order different from that found in microsomes. In contrast, the effect on LDH release was significant only for silybin and isosilybin, the other compounds being inactive on this parameter.


Related Compounds

Related Articles:

[Silymarin in the treatment of chronic liver diseases: past and future].

2008-12-21

[Orv. Hetil. 149(51) , 2413-8, (2008)]

Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry.

2006-05-26

[J. Chromatogr. A. 1116(1-2) , 57-68, (2006)]

Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.

2008-07-01

[Int. J. Cancer 123(1) , 41-50, (2008)]

Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry.

2007-01-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 845(1) , 95-103, (2007)]

Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.

2007-05-01

[Eur. J. Pharm. Biopharm. 66(2) , 210-9, (2007)]

More Articles...